Andromachi (Machi) Scaradavou, MD

Andromachi (Machi) Scaradavou, MD

I am a pediatric hematologist and oncologist with extensive experience in the use of cord blood transplants to treat babies, children, and young adults with leukemia, lymphoma, and other cancers and blood diseases.

Umbilical cord blood from healthy newborns is an excellent source of stem cells to rebuild a patient’s immune and blood systems. At Memorial Sloan Kettering, we try to present patients and their families with different treatment options, tailored to their individual situations. Cord blood has a number of advantages over blood or bone marrow from an unrelated donor. It is not necessary to find a perfect HLA (tissue type) match, making it particularly attractive for patients of ethnic minorities. Cord blood is more rapidly available, and there is a lower risk of a serious transplant complication called graft-versus-host disease, which occurs when the transplanted cells attack the normal tissues of the recipient’s body.

Appointments for New Patients
Clinical Expertise

Pediatric Hematology and Oncology; Cord Blood Transplantation for Hematologic Disorders

Languages Spoken

MD, University of Athens Medical School (Greece)


Massachusetts General Hospital/Harvard Medical School


Memorial Sloan Kettering Cancer Center; Lindsley f. Kimball Research Institute, New York Blood Center

Board Certifications

Pediatarics; Pediatric Hematology-Oncology

Publications by Andromachi (Machi) Scaradavou
Visit PubMed for full listing of Andromachi (Machi) Scaradavou journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.